Biological nanopore-based mRNA (messenger Ribonucleic Acid) detection system and detection method
Through the biological nanopore-based mRNA detection system, the nanopore probe and protease hydrolysis reaction is used to solve the problem that the detection results in the prior art are susceptible to environmental impact, and high-sensitivity, fast and low-cost mRNA detection is achieved, avoiding the The emergence of false positive and false negative results.
Patent Information
- Application Number
- CN202411112750.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-12
AI Technical Summary
The existing mRNA detection methods have problems such as the detection results being easily affected by environmental factors, taking a long time, strict usage requirements, and being prone to false positive or false negative results.
Using a biological nanopore-based mRNA detection system, the target mRNA detection probe is used to capture the target mRNA in cell samples, and the supernatant is obtained through protease hydrolysis reaction, and the magnetic stand is used for separation and detection to avoid impurities in the real sample. Molecular interference enables qualitative and quantitative detection of mRNA.
It achieves simple operation, high sensitivity and fast detection speed, avoids blockage and low resolution caused by direct action of nanopores, and obtains detection results similar to qPCR, reducing detection costs.
Smart Images

Figure CN118932032A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of bio-nano detection, and in particular relates to an mRNA detection system and a detection method based on bio-nanopores. Background Art
[0002] In the 1960s, scientists first discovered mRNA and proved that it is an important substance in cell fluid and organelles. mRNA is a DNA transcription product, which translates the genetic information of DNA into protein through codons and is the "messenger" between genetic information and protein expression. Therefore, mRNA can be used as an indicator to reflect the state of the body and provide an effective basis for clinical disease diagnosis and drug treatment.
[0003] At present, there are many methods for mRNA detection, and mature commercial methods include sequencing, Northern blot, and polymerase chain reaction (PCR). Sequencing has the advantages of high throughput, high sensitivity, and high degree of automation, and can simultaneously complete the research of traditional genomics and functional genomics, but it has the disadvantages of high detection cost and long time consumption. The Northern blot method can perform quantitative analysis on mRNA. Although the results are reliable, it needs to go through steps such as sample extraction and preparation, sample transfer, probe labeling, hybridization, and membrane washing, and the operation process is cumbersome. PCR technology has high sensitivity by amplifying the target nucleic acid, but it has the disadvantages of long time consumption, strict usage requirements, and easy false positive or false negative results.
[0004] Researchers have also tried to innovate detection technology using methods such as fluorescence, electrochemistry, and chemiluminescence, but there are also some shortcomings. Although fluorescence detection has the advantages of high sensitivity, high selectivity, and simple operation, it is easily affected by environmental factors, such as Stokes shift, photostability, and quenching effect. Although the electrochemical method is simple, easy to use, highly sensitive, and accurate, it is also easily disturbed by the detection environment, such as impurities in biological samples or mobile phases, dissolved oxygen and temperature in the mobile phase, etc. In addition, the differences between electrodes also affect the detection results to a certain extent. Chemiluminescence has the advantages of high sensitivity, simple instrumentation, low detection limit, and wide linear range, but it also needs to solve problems such as short luminescence process, low detection accuracy, and residual contamination of reagents during the detection process. Summary of the invention
[0005] Based on the technical problems existing in the prior art, the present invention provides an mRNA detection system and detection method based on biological nanopores. The present invention solves the problem that the detection results in the detection method of the prior art scheme are easily affected by the detection environment, and has the advantages of simple operation, high sensitivity, and fast detection speed.
[0006] According to the first aspect of the technical solution of the present invention, the present invention provides an mRNA detection system based on biological nanopores, which uses a nanopore mRNA detection probe to capture the target mRNA in a cell sample, obtains a supernatant through a protease hydrolysis reaction, and constructs a nanopore to detect the supernatant.
[0007] Preferably, the mRNA detection system based on biological nanopore comprises a first mRNA detection probe, a second mRNA detection probe, a magnetic frame, a protein nanopore and a nanopore sample detection pool; the first mRNA detection probe is formed by combining DNA and a polypeptide; the combination of DNA and polypeptide is streptavidin and biotin, click chemistry, bioorthogonal reaction or coupling reaction; DNA can specifically bind to the target mRNA through base complementary pairing; the polypeptide part can be hydrolyzed by protease; the second mRNA detection probe is composed of DNA modified with streptavidin; the DNA sequence of the second mRNA detection probe is different from the DNA sequence in the first mRNA detection probe, and it can also specifically bind to the target mRNA through base complementary pairing; it can bind to the biotin-modified magnetic beads through the action of streptavidin and biotin.
[0008] Furthermore, in an mRNA detection system based on biological nanopores, the target mRNA is derived from cells and body fluids (preferably blood, saliva, and sweat), and needs to be extracted in advance and captured as a target by the mRNA detection probe.
[0009] Preferably, the protease hydrolysis reaction acts on the fixed-state probe, that is, the protease hydrolyzes the fixed-state probe, the complete fixed-state probe is composed of the first mRNA detection probe, the second mRNA detection probe and the target mRNA, and the fixed-state probe is formed by the second mRNA detection probe and the surface-modified magnetic beads; the protease acts on the polypeptide part of the first mRNA detection probe, the protease can be a serine protease, a thiol protease, a metalloprotease or an aspartic acid protease, and the polypeptide part needs to be able to be hydrolyzed by the selected protease.
[0010] Furthermore, the protein nanopore is a protein nanopore of α-hemolysin nanopore, Mycobacterium smegmatis membrane protein A nanopore or Aeromonas lysin nanopore.
[0011] Preferably, the nanopore sample detection pool is composed of polytetrafluoroethylene, and the sample pool is separated into a cis chamber and a trans chamber by a polytetrafluoroethylene film; wherein the polytetrafluoroethylene film is provided with holes with a pore size of 100-150 μm for supporting the phospholipid bilayer so that the protein nanopore can be embedded.
[0012] The target mRNA to be detected is an mRNA sample extracted from cells and body fluids, and the target mRNA capture and clear solution production are performed according to the following steps:
[0013] (1) fully mixing the first mRNA detection probe, the second mRNA detection probe and the mRNA to be detected;
[0014] (2) adding magnetic beads and waiting for full reaction; the magnetic beads fully react with the second mRNA detection probe containing the target mRNA and the first mRNA detection probe;
[0015] (3) Add protease and react at 37°C. After the reaction is complete, use a magnetic rack to separate the magnetic beads from the liquid and retain the clear liquid.
[0016] According to the second aspect of the technical solution of the present invention, the present invention provides a method for detecting cell mRNA based on biological nanopore, which comprises the following steps:
[0017] Step S1: cell recovery and cell culture;
[0018] Step S2: cell counting and plating; perform trypsin digestion on the cells cultured in step S1, add any volume of 1.5 mL to 5 mL of fresh DMEM culture medium along the wall of the culture flask or culture dish to resuspend the cells, and gently blow the cells with a pipette to ensure that each cell is covered with the culture medium to form a single cell suspension;
[0019] Step S3: Extraction of total cellular RNA.
[0020] Further, step S1 specifically includes step S11: taking out the frozen SMMC-7721 cells from liquid nitrogen, and slowly heating the cryotube to room temperature or to any temperature between 3°C and 8°C, and then placing it in a water bath preheated to any temperature between 35°C and 38.5°C to revive the frozen cells, and the thawing time is 50 seconds to 120 seconds; after the SMMC-7721 cells are completely thawed, use a centrifuge for shaking centrifugation, and the parameters of the centrifuge are set to a speed of 900-1100 rpm and a working time of 3 minutes to 6 minutes, so that the cells are precipitated to the bottom of the tube.
[0021] Preferably, the frozen SMMC-7721 cells are frozen in cryovials; the temperature of the water bath is 37° C., and the thawing time is 70 seconds.
[0022] Compared with the prior art, the mRNA detection system and detection method based on biological nanopores of the present invention have the following beneficial technical effects:
[0023] 1. The present invention can achieve target mRNA identification and capture by switching the mRNA probe from a free state to a fixed state, while avoiding the interference of impurity molecules in the real sample on the phospholipid bilayer and maintaining the stability of the phospholipid bilayer.
[0024] 2. The present invention uses the polypeptide product produced by protease hydrolysis as a signal output probe, uses a nanopore to analyze and detect it, and realizes qualitative and quantitative detection of mRNA by identifying the signal of the polypeptide product, avoiding direct interaction between mRNA and nanopore, resulting in blockage of nanopore and low resolution.
[0025] 3. The present invention can give full play to the advantages of nanopore detection such as low cost, label-free, rapid, and portable, and realize the rapid detection of mRNA in cell samples, obtaining results similar to qPCR. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 is a schematic diagram of the process of mRNA detection technology based on biological nanopore according to the present invention;
[0027] Figure 2 is a schematic diagram of an mRNA detection system based on a biological nanopore according to the present invention;
[0028] Figure 3 is a schematic diagram of the relationship between the relative current amplitude and the residence time of each analyte in the nanopore detection according to the present invention;
[0029] Figure 4 This is a schematic diagram of the change of P2RX7 mRNA level of SMMC cells under the action of carrimycin detected by the nanopore of the present invention;
[0030] Description of reference numerals in the accompanying drawings:
[0031] Figure 3 (a) is the second mRNA detection probe 2; (b) is the target mRNA combined with the second mRNA detection probe 2; (c) is the P2RX7 combined with the first mRNA detection probe and the second mRNA detection probe 2; (d) is the product of the P2RX7 combined with the first mRNA detection probe and the second mRNA detection probe 2, followed by the addition of magnetic beads and the trypsin hydrolysis reaction. The nanopore detection was performed in a 1M NaCl, 10mM Tris (pH7.5) electrolyte solution with an applied voltage of -40mV.
[0032] Figure 4(a) shows the P2RX7 mRNA level in SMMC cells without drug treatment; (b) shows the P2RX7 mRNA level in SMMC cells treated with 10 μg / mL drug; (c) shows the nanopore detection results of P2RX7 mRNA level in SMMC cells before and after drug treatment; (d) shows the qPCR detection results of P2RX7 mRNA level in SMMC cells before and after drug treatment. Nanopore detection was performed in 1M NaCl, 10mMTris (pH7.5) electrolyte solution with an applied voltage of -40mV. DETAILED DESCRIPTION
[0033] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be clearly and completely described below in conjunction with the drawings of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0034] It should also be noted that, for ease of description, only the parts related to the invention are shown in the drawings. In the absence of conflict, the embodiments of the present invention and the features in the embodiments can be combined with each other.
[0035] It should be noted that the concepts such as "first" and "second" mentioned in the present invention are only used to distinguish different devices, modules or units, and are not used to limit the order or interdependence of the functions performed by these devices, modules or units.
[0036] It should be noted that the modifications of "one" and "multiple" mentioned in the present invention are illustrative and non-restrictive. Those skilled in the art should understand that unless otherwise clearly indicated in the context, it should be understood as "one or more". The experimental methods in the following examples are all conventional methods unless otherwise specified. The test materials used in the following examples are all purchased from conventional biochemical reagent stores unless otherwise specified. The quantitative tests in the following examples are all set up for three repeated experiments, and the results are averaged.
[0037] The present invention provides an mRNA detection system and method based on biological nanopores, which belong to the field of medical biological nano-detection, and specifically to the field of mRNA detection technology. The present invention captures the target mRNA in the cell sample by a nanopore mRNA detection probe, obtains the supernatant to be tested by protease hydrolysis reaction and magnetic separation, and detects the supernatant to be tested based on the constructed nanopore. The present invention solves the shortcomings of the prior art such as long time consumption, strict use requirements, and easy occurrence of false positive or false negative results, and also solves the technical problems such as the detection results are easily affected by environmental factors.
[0038] Further, such as Figure 2 As shown, the mRNA detection system based on biological nanopore of the present invention includes a first mRNA detection probe 1, a second mRNA detection probe 2, a magnetic frame, a protein nanopore and a nanopore sample detection pool; the mRNA detection system based on biological nanopore uses the nanopore mRNA detection probe to capture the target mRNA in the cell sample, obtains the supernatant to be tested through protease hydrolysis reaction and magnetic separation, and detects the supernatant to be tested based on the constructed nanopore.
[0039] Figure 2 The first mRNA detection probe 1, the second mRNA detection probe 2 and the target mRNA shown in the figure can be transformed from a free state to a fixed state after being bound by the magnetic beads. Further, the first mRNA detection probe 1, the second mRNA detection probe 2 and the target mRNA can freely diffuse and react in the solution, and the mRNA detection probe is composed of two types, namely: the first mRNA detection probe 1 formed by the combination of a DNA fragment and a polypeptide fragment, and the second mRNA detection probe 2 composed of a DNA probe modified with streptavidin.
[0040] The first mRNA detection probe 1 is composed of DNA and polypeptide; the binding mode of DNA and polypeptide can be the binding mode of streptavidin and biotin interaction, click chemistry binding mode, bioorthogonal reaction binding mode or coupling reaction binding mode; the DNA probe can specifically bind to the target mRNA through base complementary pairing, and the polypeptide part can be hydrolyzed by protease.
[0041] The second mRNA detection probe 2 is composed of a DNA probe modified with streptavidin; the DNA sequence in the second mRNA detection probe 2 is different from the DNA sequence in the first mRNA detection probe 1, but the DNA in the second mRNA detection probe 2 can also specifically bind to the target mRNA through base complementary pairing.
[0042] The second mRNA detection probe 2 can be combined with the surface-modified magnetic beads through the chain end-modified DNA, so that the mRNA detection probe is transformed from a free state to a fixed state. Further, the DNA probe is combined with the magnetic beads through the interaction between streptavidin and biotin on the magnetic beads. In another embodiment, the DNA fragments in the first mRNA detection probe 1 and the second mRNA detection probe 2 are determined by the mRNA sequence to be detected, and the DNA sequences in the first mRNA detection probe 1 and the second mRNA detection probe 2 are different; the fixed state probe is produced by combining the chain end-modified DNA in the second mRNA detection probe 2 with the surface-modified magnetic beads; the binding mode of the DNA in the second mRNA detection probe 2 and the magnetic beads can be the action of streptavidin and biotin, the action of sulfur-gold bond, and the coupling reaction.
[0043] The protein nanopore in the system can be a protein nanopore such as α-hemolysin (αHL) nanopore, Mycobacterium smegmatis membrane protein A (MspA) nanopore or Aerolysin nanopore. The protease hydrolysis reaction product needs to be obtained by using a magnetic stand, and the protease hydrolysis reaction product is the clear liquid part.
[0044] The nanopore sample detection pool is a sample pool made of polytetrafluoroethylene, and the nanopore sample detection pool is separated into a cis chamber and a trans chamber by a polytetrafluoroethylene film; the polytetrafluoroethylene film has a hole with a pore size of 100-150μm, which is used to support the phospholipid bilayer to facilitate the embedding of protein nanopores.
[0045] The target mRNA in the mRNA detection system based on biological nanopore of the present invention is derived from cells and body fluids (such as blood, saliva, sweat, etc.), and the target mRNA needs to be extracted in advance. The target mRNA as the analyte is captured by the mRNA detection probe.
[0046] The target mRNA to be detected can be an mRNA sample extracted from cells and body fluids, and the target mRNA capture to produce the test clear solution can be performed according to the following steps:
[0047] (1) fully mixing the first mRNA detection probe 1, the second mRNA detection probe 2 and the mRNA to be detected (target mRNA);
[0048] (2) adding magnetic beads and waiting for full reaction; the magnetic beads fully react with the second mRNA detection probe containing the target mRNA and the first mRNA detection probe;
[0049] (3) Add protease and react at 37°C. After the reaction is complete, use a magnetic rack to separate the magnetic beads from the liquid and retain the clear liquid.
[0050] Implementation of protease hydrolysis of fixed-state probe: In the presence of target mRNA, the first mRNA detection probe 1, the target mRNA, and the second mRNA detection probe 2 form a partially complementary double-stranded structure, and the second mRNA detection probe 2 is combined with the magnetic beads to fix the formed double-stranded structure on the surface of the magnetic beads, and the transformation from the free state probe to the fixed state probe is completed under the action of the magnetic frame. Protease hydrolysis of the fixed-state probe is implemented by combining the second mRNA detection probe 2 with the surface-modified magnetic beads; the protease acts on the polypeptide part in the first mRNA detection probe 1, and the protease can be a serine protease, a thiol protease, a metalloprotease or an aspartic acid protease, etc. In another embodiment, the object of the protease hydrolysis reaction is a polypeptide fragment in the first mRNA detection probe 1, and the polypeptide fragment has an amino acid sequence that can be specifically hydrolyzed by the corresponding protease.
[0051] In another embodiment, the present invention provides a method for detecting cell mRNA based on biological nanopore, which comprises the following steps:
[0052] Step S1: cell recovery and cell culture; specifically, the frozen SMMC-7721 cells are taken out from liquid nitrogen and placed in a water bath preheated to 35°C-38.5°C for recovery; after the SMMC-7721 cells are completely thawed, the recovered SMMC-7721 cells are cultured.
[0053] In a preferred embodiment, the temperature of the water bath is constant at 37°C; after thawing, the cells are precipitated in the lower layer of the cryopreservation tube, and the upper layer of the cryopreservation tube is a clear liquid layer; after discarding the clear liquid layer on the upper layer of the cryopreservation tube, 1 mL of fresh DMEM culture medium is added to the cryopreservation tube, and the cell precipitation is blown by a pipette, that is, the mixture of cells and fresh DMEM culture medium is continuously sucked by a pipette to make it fully mixed to obtain a cell suspension; the cell suspension is transferred to a 10 cm culture dish, and fresh DMEM culture medium is supplemented in the cell suspension to a total volume of 7 mL, and then the cell suspension with fresh DMEM culture medium is placed in a constant temperature cell culture incubator with a temperature of 37°C and filled with 5% carbon dioxide for 7-10 hours, preferably 8 hours, and then the DMEM culture medium is replaced. In this step, all DMEM culture media are added with 10% FBS serum and 5% penicillin-streptomycin.
[0054] In another preferred embodiment, step S1 specifically includes the following steps:
[0055] Step S11: Take out the frozen SMMC-7721 cells (liver cancer cells) (frozen SMMC-7721 cells (liver cancer cells) are frozen in a cryopreservation tube) from liquid nitrogen, and slowly heat the cryopreservation tube to room temperature or to any temperature between 3°C and 8°C, and then put it into a water bath preheated to any temperature between 35°C and 38.5°C to revive the frozen cells, and the thawing time is 50 seconds to 120 seconds; preferably, the temperature of the water bath is 37°C and the thawing time is 70 seconds; when the SMMC-7721 cells are completely thawed, use a centrifuge for shaking centrifugation, and the parameters of the centrifuge are set to a speed of 900-1100 rpm and a working time of 3 minutes to 6 minutes; preferably, the speed is 1000 rpm and the working time is 5 minutes, so that the cells are precipitated to the bottom of the tube.
[0056] Step S12: Take the solution after centrifugation in step S11 to the clean bench, and slowly pour the supernatant (the clear night layer on the upper layer of the cryopreservation tube) into the prepared receiving container to obtain the first extract on the lower layer of the cryopreservation tube; during the pouring process, the centrifuged solution should be kept stable, and violent shaking of the centrifuged solution should be avoided as much as possible to avoid re-suspending the cells.
[0057] Step S13: Add 1 mL of fresh DMEM culture medium to the first extract obtained in step S12, and oscillate to mix, transfer the first extract mixture to a cryopreservation tube, and use a pipette to gently blow the cryopreservation tube to precipitate the cells, which can further help the cell precipitates to be evenly dispersed in the culture medium to avoid cell agglomeration or damage. DMEM culture medium (Dulbecco's Modified Eagle Medium) is an existing cell culture medium that provides cells with essential nutrients and growth factors; in this embodiment, the use of fresh DMEM culture medium during the cryopreservation process can ensure that the nutritional needs of the cells are met, and at the same time, the cells are evenly distributed by blowing, which is beneficial to the subsequent slow freezing process, thereby protecting the cells from damage to the greatest extent. Step S14: the cell suspension in step S13 is transferred to a 10 cm culture dish, fresh DMEM medium is added to a total volume of 7 mL, 10% FBS serum and 5% penicillin-streptomycin are added to the DMEM medium, and then placed in a constant temperature cell culture incubator for culture; the parameters of the constant temperature cell culture incubator are: the temperature is set to 36° C.-38.5° C., preferably 37° C., the constant temperature cell culture incubator is filled with carbon dioxide, and the concentration of carbon dioxide is set to 3%-8%, preferably 5%; the DMEM medium is replaced after 8 hours, and the replacement of the DMEM medium includes the following steps:
[0058] Step S141: prepare new DMEM culture medium; prepare an appropriate amount of fresh DMEM culture medium preheated to 37° C. for complete culture;
[0059] Step S142: removing the old culture medium; under sterile conditions, gently aspirate the old culture medium in the culture bottle or culture dish, taking care to avoid aspirating away the cells;
[0060] Step S143: washing the cells; using an appropriate amount of sterile PBS (phosphate buffered saline) to gently wash the cell surface to remove residual old culture medium and cell debris;
[0061] Step S144: Add new culture medium; add the prepared new DMEM culture medium to the culture bottle or culture dish, add fresh culture medium to a total volume of 7 mL, add 10% FBS serum and 5% penicillin-streptomycin to the DMEM culture medium
[0062] Step S145: Return to the incubator; return the culture bottle or culture dish to the 37°C constant temperature cell incubator for continued culture, and fill the constant temperature cell incubator with carbon dioxide, with the concentration of carbon dioxide set to 3%-8%.
[0063] Step S2: cell counting and plating; the cells cultured in step S1 are digested with trypsin, and after digestion with trypsin, any volume of 1.5mL-5mL of fresh DMEM culture medium is added along the wall of the culture bottle or culture dish to resuspend the cells, and the cells are gently blown with a pipette to ensure that each cell can be covered by the culture medium to form a single cell suspension; the prepared single cell suspension is mixed with a concentration of 0.3%-0.8% of any concentration of trypan blue dye (TypanBlue) at a ratio of (0.5-5):1 (volume ratio) to form a single cell mixed solution; that is, according to the volume ratio, the single cell suspension is 0.5-5 parts, and the trypan blue dye (TypanBlue) is 1 part. Trypan blue can penetrate the cell membrane of dead cells, while the cell membrane of living cells is resistant to it, so the activity of the cells can be judged by observing the staining.
[0064] Inject the single cell mixture into the holes of the cell counting plate and use a cell counter to count the cells. Count each sample three times and take the average number of live cells. Calculate the volume of cell suspension required for the target cell amount based on the cell counting results (average number of live cells); use a pipette to blow the cells evenly again and remove the precipitated 5*10 5 SMMC-7721 cells are plated in three-well plates, four-well plates, five-well plates or six-well plates (preferably six-well plates), and then DMSO (dimethyl sulfoxide) for control and 10 μg / mL of chloramphenicol are added respectively. The culture medium is changed and new drugs (DMSO (dimethyl sulfoxide) for control and 10 μg / mL of chloramphenicol) are added every day.
[0065] In a preferred embodiment, the cells cultured in step S1 are digested with trypsin. After digestion with trypsin, 2 mL of fresh DMEM culture medium is added along the wall of the culture bottle or culture dish to resuspend the cells, and the cells are gently blown with a pipette to ensure that each cell is covered with the culture medium to form a single cell suspension; the prepared single cell suspension is mixed with a 0.4% trypan blue dye (TypanBlue) in a ratio of 1:1 (volume ratio) to form a single cell mixed solution; in this embodiment, 10 μL of the single cell suspension is preferably mixed with 10 μL of 0.4% trypan blue dye (TypanBlue).
[0066] Step S3: Two days later, RNA extraction is performed, i.e., total cell RNA extraction; total cell RNA extraction includes the following specific steps:
[0067] Step S301: precooling the centrifuge to 4°C;
[0068] Step S302: Add 1 mL of fresh DMEM culture medium to the cells digested with trypsin in step S2, and gently blow the cells with a pipette to make them fall off the culture dish and form a single cell suspension; transfer the cell suspension after blowing to a 1.5 mL eppendorf tube (common consumables, centrifuge tube); during the operation, ensure the uniformity of the cell suspension to avoid cell aggregation or precipitation;
[0069] Step S303: placing the cell suspension after the beating in step S302 in a centrifuge, setting the centrifuge to a speed of 3500 rpm (revolutions per minute), and setting the centrifugation time to 5 minutes; placing the centrifuge tube containing the mixture of cells and culture medium in the centrifuge, and starting the centrifugation process; after the centrifugation is completed, the liquid and cells in the centrifuge tube will be separated into two layers, the upper layer is the culture medium supernatant, and the lower layer is the cell sediment; using a pipette or a pipette, carefully suck out the upper layer of the culture medium supernatant from the centrifuge tube and discard it, and be careful not to disturb the cell sediment in the lower layer;
[0070] Step S304: Add 1 mL of Trizol reagent refrigerated at 4°C to the EP tube, add the cell sample to the EP tube containing Trizol, and then use a pipette or a blower to fully blow and mix, and place the mixture at room temperature or at a temperature of 30°C-38°C for 5 minutes to completely separate the nucleic acid-protein complex and dissolve the cells in Trizol;
[0071] Step S305: Place the ep tube containing Trizol in step S304 on ice, add 200 μL of chloroform, and shake vigorously back and forth for 1 min;
[0072] Step S306: After cooling the ep tube containing Trizol in step S305 on ice for 10 minutes, place it in a centrifuge cooled to 4°C, set the speed of the centrifuge to 12000 rpm, and centrifuge for 15 minutes to perform centrifugation;
[0073] Step S307: After the centrifugation operation, carefully take out the ep tube, the solution in the ep tube is layered, the upper solution is transparent, and the lower solution is pink;
[0074] Step S308: Prepare a matching number of ep tubes, carefully aspirate the upper transparent liquid (about 400 μL-450 μL) in a fume hood, and transfer it to a new ep tube;
[0075] Step S309: Calculate the volume and add an equal amount of 4°C pre-cooled isopropanol in a volume ratio of 1:1, cover the lid, and gently turn the EP tube or container upside down to fully mix the isopropanol and the solution containing RNA. Note that the action should be gentle to avoid violent bubbles, because bubbles may destroy the structure of RNA; let the mixed solution stand on ice for 10 minutes;
[0076] Step S310: placing the solution after standing on ice for 10 minutes in step S309 in a pre-cooled centrifuge and centrifuging at 12,000 rpm for 15 minutes; at this time, a white plaque-like RNA precipitate is obtained at the bottom of the EP tube or the container;
[0077] Step S311: Carefully and slowly aspirate the upper clear layer of the ep tube or container and place it in another new 1.5 mL ep tube; add 1 mL (precooled at 4°C) 75% ethanol to the ep tube containing the white plaque-like RNA precipitate, vortex, and then place it in a centrifuge, set the speed of the centrifuge to 10,000 rpm, centrifuge for 15 minutes, take it out after centrifugation, and discard the ethanol;
[0078] Step S312: repeat step S311;
[0079] Step S313: After discarding the ethanol supernatant, place the ep tube on ice, open the lid of the ep tube, and air-dry it in a fume hood until the white patches of RNA become transparent, add an appropriate amount of DEPC water, and use a pipette to blow and dissolve the RNA.
[0080] In another embodiment, step S3* or two days later, Trizol is used to collect samples. Using Trizol to collect samples includes the following steps:
[0081] (1) Homogenization: directly add Trizol reagent to dissolve cells, or first use a homogenizer to homogenize cells and then add Trizol reagent;
[0082] (2) Mixing and separation: Add Trizol reagent to the homogenate sample and shake the mixture to mix well; then set the temperature of the water bath to any temperature between 30°C and 38°C for 5 minutes to completely separate the nucleic acid-protein complex;
[0083] (3) Extract RNA: Transfer the upper layer of supernatant to a new centrifuge tube and keep the cell aggregates in the lower layer;
[0084] (4) Washing and dissolving: Add isopropanol to the lower layer of cell aggregates, mix gently and let stand at room temperature for 10 minutes; discard the supernatant, add 75% ethanol (ice-cold) to wash the precipitate, and centrifuge to remove the washing solution after sufficient washing; after centrifugation again, discard the supernatant, centrifuge briefly and carefully aspirate and remove the remaining liquid; finally, add an appropriate amount of DEPC-treated H2O (RNase-free) to dissolve RNA, and the dissolution can be promoted at 65°C for 10-15 minutes.
[0085] The mRNA detection method based on biological nanopores of the present invention also involves the preparation of the solution required for nanopore detection, the construction of a free first mRNA detection probe, the reaction of the mRNA detection probe with mRNA in the cell sample before and after drug addition, the protease hydrolysis reaction and the construction of a nanopore detection system.
[0086] The preparation of the solution required for the nanopore detection includes the preparation of the following solutions:
[0087] (1) Preparation of electrolyte solution: Sodium chloride (NaCl) and tris (hydroxymethyl)aminomethane (Tris) are dissolved in deionized water, and the solution is adjusted to pH 7.5 to form an electrolyte buffer solution containing sodium chloride and tris (hydroxymethyl)aminomethane (Tris), wherein the concentration of NaCl is 1 M and the concentration of tris (hydroxymethyl)aminomethane (Tris) is 10 mM, and the deionized water containing sodium chloride (NaCl) and tris (hydroxymethyl)aminomethane (Tris) is filtered using a vacuum filter pump.
[0088] (2) Preparation of Tris buffer: Dissolve MgCl2, NaCl, and Tris-HCl in deionized water to make the concentration of Tris 1 M, and adjust the pH of the solution to 7.5.
[0089] (3) Preparation of Trypsin18AA polypeptide solution: Dissolve the Trypsin18AA polypeptide sample in DMSO solution and electrolyte solution to make the final concentration of the solution 1 mM, and store it in a -20°C refrigerator.
[0090] (4) Preparation of trypsin solution: Dissolve trypsin in enzyme-free water to obtain a 100 μg / mL solution and store it in a -20°C refrigerator.
[0091] (5) Preparation of TCEP solution: Dissolve TCEP in enzyme-free water to a concentration of 20 mM, adjust the pH to 7.0, and store in a -4°C refrigerator.
[0092] (6) Preparation of MPP2RX7 DNA solution: Dissolve MPP2RX7 DNA in the above-mentioned Tris buffer to a final concentration of 100 μM and store in a -20°C refrigerator.
[0093] (7) Preparation of FPP2RX7 DNA solution: Dissolve FPP2RX7 DNA in the above Tris buffer to a final concentration of 100 μM and store in a -20°C refrigerator.
[0094] (8) Preparation of P2RX7 DNA solution: Dissolve P2RX7 DNA in the above-mentioned Tris buffer to a final concentration of 100 μM and store in a -20°C refrigerator.
[0095] The construction of the free first mRNA detection probe 1 includes the following steps:.
[0096] Step W11, mix 50 μL of the prepared FPP2RX7 DNA solution required for the above-mentioned nanopore detection solution and 10 μL of TCEP solution in a centrifuge tube, place the centrifuge tube in a metal bath, set the heating temperature of the metal bath to 37°C, and rotate the centrifuge tube at 300 r / min (revolutions / minute) to allow the prepared 50 μL of FPP2RX7 DNA solution required for the above-mentioned nanopore detection solution and 10 μL of TCEP solution to react at a constant temperature in the metal bath for 2 hours.
[0097] Step W12, after the metal bath reaction of the mixed sample is completed, use a pipette or an appropriate tool to take 100 μL of the prepared 1 mM Trypsin18AA polypeptide solution of the solution required for the above-mentioned nanopore detection, slowly add the Trypsin18AA polypeptide solution to the prepared centrifuge tube, place the centrifuge tube containing the Trypsin18AA polypeptide solution in a spiral mixer, set the speed to 500 rpm-1500 rpm, and spirally mix the solution in the centrifuge tube. Preferably, the spiral mixer rotates at a speed of 1000 rpm to mix the polypeptide solution in the centrifuge tube at the set speed; when the set mixing time is reached, turn off the spiral mixer.
[0098] Step W13, placing the mixed solution obtained in step W12 in a metal bath at a constant temperature of 37° C. and heating it at a rotation speed of 300 rpm.
[0099] Step W14, the polypeptide solution in the centrifuge tube is mixed at a set speed for 12 hours and kept at a constant temperature of 37° C. to obtain the first mRNA detection probe 1 in a free state.
[0100] The mRNA detection probe reacts with the mRNA in the cell sample before and after drug addition, including the free probe binding to the mRNA and binding to the magnetic beads, which specifically includes the following steps:
[0101] Step W21: free probe binds to mRNA;
[0102] Take the prepared MP P2RX7 (120 μL, 5 μM, i.e., the second mRNA detection probe 2) and 20 μL of the mRNA extraction solution of SMMC cells in the above nanopore detection solution and mix them in a centrifuge tube, mix them in a centrifuge tube, and mix them with a spiral mixer; preferably, mix them evenly at a speed of 1000 rpm, and continue mixing for 30 minutes. Then place the mixed solution in a metal bath, react in the metal bath at a constant temperature of 95°C for 5 minutes, and cool to room temperature.
[0103] After the above reaction is completed, the free first mRNA detection probe 1 (5 μL, 656.25 μM) in step W1 is added to the centrifuge tube, mixed with a spiral mixer, placed in a metal bath at a constant temperature of 95°C, and the reaction is continued for 5 minutes; after the free probe is fully combined with the mRNA, it is cooled to room temperature.
[0104] Step W22: combining with magnetic beads; further comprising the following steps:
[0105] (1) Wash the beads at least three times with Tris buffer at pH 7.5;
[0106] (2) Add 131 μL of the solution prepared in step W21 above to the washed magnetic beads, mix well, and place the mixture in a metal constant temperature mixer to react at a constant temperature of 37° C. and a speed of 300 r / min for 1 hour;
[0107] Step W23: Washing the magnetic beads: Use a magnetic separation rack to remove the supernatant from the magnetic bead mixture obtained in step W22, and then wash it five times with Tris buffer at pH 7.5 to remove impurities such as unbound MPP2RX7, remaining mRNA, and free phase probes, and retain the magnetic beads for later use.
[0108] The protease hydrolysis reaction is used to extract the supernatant for detection, which includes the following steps:
[0109] Step W31: Add the electrolyte solution (50 μL, 1 M NaCl, 10 mM Tris, pH 7.5) prepared for the above-mentioned nanopore detection solution to the magnetic beads to evenly diffuse the magnetic beads;
[0110] Step W32: Add 1 μL (concentration 5 μg / mL) of trypsin solution to the centrifuge tube, mix thoroughly, and react for 30 min in a metal bath at 37°C and 300 r / min. After the reaction, extract the supernatant using a magnetic separation rack, add the extracted supernatant to the centrifuge tube, and store the centrifuge tube containing the supernatant in a -20°C refrigerator freezer for subsequent nanopore detection.
[0111] The construction of the nanopore detection system includes the following steps:
[0112] Step W41: a supporting film is disposed in the middle of the nanopore sample detection pool. The supporting film separates the nanopore sample detection pool into a cis cavity and a trans cavity. The supporting film is covered with holes with a pore size of 100 μm. The material of the supporting film may be a polytetrafluoroethylene membrane.
[0113] Step W42: A phospholipid bilayer is formed on the hole (pore size 100 μm) using the Montal-Muller method; and the electrolyte solution is injected into the cis cavity and the trans cavity respectively.
[0114] Step W43: Two electrodes are placed in the cis cavity and the trans cavity containing the solution at both ends of the supporting film, respectively, and both electrodes are connected to the patch clamp; both electrodes are silver electrode materials coated with silver chloride.
[0115] Step W44: After the α-hemolysin in the electrolyte solution is embedded in the phospholipid bilayer on the pore (pore diameter 100 μm), a complete nanopore detection and analysis system is formed.
[0116] The sample is detected using a biological nanopore-based mRNA detection system, i.e., a biological nanopore-based mRNA detection method, which includes the following detection steps:
[0117] Step W51: Add the supernatant after the protease hydrolysis reaction to the trans cavity of the above-mentioned nanopore sample pool, apply an external electric field, and use a patch clamp to collect the electric pulse signal at this time.
[0118] Step W52: Recording the single-channel electrical pulse signal in real time, preferably using PatchMaster to record the single-channel electrical pulse signal in real time;
[0119] Step W53: analyzing the collected single-channel electric pulse signal; preferably using the collected single-channel electric pulse signal to form a data file, and using the software clamfit to analyze the electric pulse signal data file;
[0120] Step W54: Perform statistical analysis based on the signal amplitude and current blocking time to obtain characterization data of the protease hydrolyzed polypeptide product, such as Figure 3 shown.
[0121] Step W55: The mRNA of the cells before drug administration (SMMC MocK) and after drug administration (SMMC 10CA) were detected using the nanopore method. The retention time, I r / I o .
[0122] The experimental results show that the nanopore detection sample will obtain characteristic signals, which can realize the detection of mRNA in cell samples and reflect the regulation level of drugs on mRNA in cell samples, proving that the nanopore-based mRNA detection method is feasible for mRNA detection in real samples. Figure 4 shown.
[0123] The present invention will be further described below in conjunction with the accompanying drawings. Figure 1 This is a schematic diagram of the mRNA detection process based on biological nanopores according to the present invention. First, a drug exposure experiment is performed on a cell sample, and then the mRNA of the drug-exposed cells is extracted; various mRNA detection probes required for mRNA detection are prepared, and the mRNA detection probes are mixed with the mRNA sample and fully reacted to capture the target mRNA; then, protease is added to the mRNA detection probe for protease hydrolysis reaction, and the clear liquid is extracted by magnetic separation; and the clear liquid detection is carried out using the constructed nanopore.
[0124] Figure 2 Schematic diagram of the implementation scheme of nanopore mRNA detection used in the present invention, which includes the following steps:
[0125] The first step is to conduct a drug-experiment on the cell sample; the second step is to extract the mRNA of the drug-experienced cells; the third step is to add the second mRNA detection probe 2; the fourth step is to add the first mRNA detection probe 1; the fifth step is to add magnetic beads; the sixth step is to add protease and obtain the clear solution using a magnetic stand; the seventh step is to detect the clear solution using a nanopore.
[0126] Figure 3 This is a schematic diagram of the verification of the method of nanopore detection of mRNA, which uses P2RX7 as the detection object and replaces mRNA with artificially synthesized DNA, and detects it through nanopore detection technology to verify the feasibility of the established nanopore mRNA. Figure 3 (a) is verified using the second mRNA detection probe 2; Figure 3 (b) is verification by combining the target mRNA with the second mRNA detection probe 2; Figure 3 (c) is a verification using P2RX7 combined with the first mRNA detection probe 1 and the second mRNA detection probe 2; Figure 3 (d) is the product of the reaction of adding magnetic beads and performing trypsin hydrolysis after P2RX7 is combined with the first mRNA detection probe 1 and the second mRNA detection probe 2 for verification. The nanopore detection was performed in a 1M NaCl, 10mM Tris (pH 7.5) electrolyte solution with an applied voltage of -40mV.
[0127] Figure 4This is a schematic diagram of the mRNA regulation level under the action of nanopore detection drugs. The nanopore detection platform is used to detect and analyze cells before drug addition (SMMCMocK) and after drug addition (SMMC10CA). P2RX7mRNA is used as the detection target to study the regulation of drugs on mRNA in cells. PCR was used for verification and compared with the nanopore detection results. Figure 4 (a) shows the P2RX7 mRNA level in untreated SMMC cells; Figure 4 (b) shows the P2RX7 mRNA level in SMMC cells treated with 10 μg / mL drug; Figure 4 (c) shows the nanopore detection results of P2RX7 mRNA levels in SMMC cells before and after drug administration; Figure 4 (d) is the qPCR detection result of P2RX7 mRNA level in SMMC cells before and after drug administration. Nanopore detection was performed in 1M NaCl, 10mM Tris (pH7.5) electrolyte solution with an applied voltage of -40mV.
[0128] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. An mRNA detection system based on biological nanopore, characterized in that: It uses a nanopore mRNA detection probe to capture the target mRNA in the cell sample, obtains the supernatant to be tested through protease hydrolysis reaction and magnetic separation, and constructs a nanopore to detect the supernatant to be tested.
2. The mRNA detection system based on biological nanopore according to claim 1, characterized in that: It comprises a first mRNA detection probe (1), a second mRNA detection probe (2), a magnetic frame, a protein nanopore and a nanopore sample detection pool; The first mRNA detection probe (1) is formed by combining DNA and a polypeptide; the combination of DNA and polypeptide is carried out by the action of streptavidin and biotin, click chemistry, bioorthogonal reaction or coupling reaction; the DNA can specifically combine with the target mRNA through complementary base pairing; the polypeptide part can be hydrolyzed by protease; The second mRNA detection probe (2) is composed of DNA modified with streptavidin; the DNA sequence of the second mRNA detection probe (2) is different from the DNA sequence in the first mRNA detection probe (1), and it can also specifically bind to the target mRNA through base complementary pairing; it can bind to the biotin-modified magnetic beads through the action of streptavidin and biotin.
3. The mRNA detection system based on biological nanopore according to claim 2, characterized in that: The target mRNA originates from cells and body fluids and needs to be extracted in advance and captured as a target by the mRNA detection probe.
4. The mRNA detection system based on biological nanopore according to claim 2, characterized in that: The protease hydrolysis reaction acts on the fixed-state probe, that is, the protease hydrolyzes the fixed-state probe, the complete fixed-state probe is composed of a first mRNA detection probe (1), a second mRNA detection probe (2) and a target mRNA, and the fixed-state probe is formed by combining the second mRNA detection probe with surface-modified magnetic beads; the protease acts on the polypeptide part in the first mRNA detection probe, and the protease is a serine protease, a thiol protease, a metalloprotease or an aspartic acid protease.
5. The mRNA detection system based on biological nanopore according to claim 2, characterized in that: The protein nanopore is a protein nanopore of α-hemolysin nanopore, Mycobacterium smegmatis membrane protein A nanopore or Aeromonas lysin nanopore.
6. The mRNA detection system based on biological nanopore according to claim 2, characterized in that: The nanopore sample detection cell is made of polytetrafluoroethylene, and the sample cell is divided into a cis chamber and a trans chamber by a polytetrafluoroethylene film; The polytetrafluoroethylene film is provided with holes with a pore size of 100-150μm to support the phospholipid bilayer so that protein nanopores can be embedded.
7. The mRNA detection system based on biological nanopore according to claim 2, characterized in that: The target mRNA to be tested is an mRNA sample extracted from cells and body fluids. The target mRNA is captured and the clear solution to be tested is produced according to the following steps: (1) fully mixing the first mRNA detection probe, the second mRNA detection probe and the mRNA to be detected; (2) adding magnetic beads and waiting for full reaction; the magnetic beads fully react with the second mRNA detection probe containing the target mRNA and the first mRNA detection probe; (3) Add protease and react at 37°C. After the reaction is complete, use a magnetic rack to separate the magnetic beads from the liquid and retain the clear liquid.
8. A method for detecting cell mRNA based on biological nanopores, characterized in that: It includes the following steps: Step S1: cell recovery and cell culture; Step S2: cell counting and plating; perform trypsin digestion on the cells cultured in step S1, add any volume of 1.5 mL to 5 mL of fresh DMEM culture medium along the wall of the culture flask or culture dish to resuspend the cells, and gently blow the cells with a pipette to ensure that each cell is covered with the culture medium to form a single cell suspension; Step S3: Extraction of total cellular RNA.
9. The mRNA detection method based on biological nanopore according to claim 2, characterized in that: Step S1 specifically includes step S11: taking out the frozen SMMC-7721 cells from liquid nitrogen, and slowly heating the cryotube to room temperature or to any temperature between 3°C and 8°C, and then placing the cryotube in a water bath preheated to any temperature between 35°C and 38.5°C to revive the frozen cells, and the thawing time is 50 seconds to 120 seconds; after the SMMC-7721 cells are completely thawed, use a centrifuge for shaking centrifugation, and the parameters of the centrifuge are set to a speed of 900-1100 rpm and a working time of 3 minutes to 6 minutes, so that the cells are precipitated to the bottom of the tube.
10. The mRNA detection method based on biological nanopore according to claim 9, characterized in that: The cryopreserved SMMC-7721 cells were stored in cryovials; the temperature of the water bath was 37°C and the thawing time was 70 seconds.
